Literature DB >> 25708596

Recombinant adeno-associated viral (rAAV) vectors mediate efficient gene transduction in cultured neonatal and adult microglia.

Wei Su1, John Kang1, Bryce Sopher1, James Gillespie1, Macarena S Aloi2, Guy L Odom1, Stephanie Hopkins1, Amanda Case1, David B Wang3, Jeffrey S Chamberlain1, Gwenn A Garden1,2,4.   

Abstract

Microglia are a specialized population of myeloid cells that mediate CNS innate immune responses. Efforts to identify the cellular and molecular mechanisms that regulate microglia behaviors have been hampered by the lack of effective tools for manipulating gene expression. Cultured microglia are refractory to most chemical and electrical transfection methods, yielding little or no gene delivery and causing toxicity and/or inflammatory activation. Recombinant adeno-associated viral (rAAVs) vectors are non-enveloped, single-stranded DNA vectors commonly used to transduce many primary cell types and tissues. In this study, we evaluated the feasibility and efficiency of utilizing rAAV serotype 2 (rAAV2) to modulate gene expression in cultured microglia. rAAV2 yields high transduction and causes minimal toxicity or inflammatory response in both neonatal and adult microglia. To demonstrate that rAAV transduction can induce functional protein expression, we used rAAV2 expressing Cre recombinase to successfully excise a LoxP-flanked miR155 gene in cultured microglia. We further evaluated rAAV serotypes 5, 6, 8, and 9, and observed that all efficiently transduced cultured microglia to varying degrees of success and caused little or no alteration in inflammatory gene expression. These results provide strong encouragement for the application of rAAV-mediated gene expression in microglia for mechanistic and therapeutic purposes. Neonatal microglia are functionally distinct from adult microglia, although the majority of in vitro studies utilize rodent neonatal microglia cultures because of difficulties of culturing adult cells. In addition, cultured microglia are refractory to most methods for modifying gene expression. Here, we developed a novel protocol for culturing adult microglia and evaluated the feasibility and efficiency of utilizing Recombinant Adeno-Associated Virus (rAAV) to modulate gene expression in cultured microglia.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  heparin; in vitro; microglia; recombinant Adeno-associated Viral (rAAV) vector

Mesh:

Year:  2015        PMID: 25708596      PMCID: PMC4547919          DOI: 10.1111/jnc.13081

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  67 in total

Review 1.  Immune function of microglia.

Authors:  F Aloisi
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

2.  Developmental plasticity of CNS microglia.

Authors:  L Santambrogio; S L Belyanskaya; F R Fischer; B Cipriani; C F Brosnan; P Ricciardi-Castagnoli; L J Stern; J L Strominger; R Riese
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

3.  The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Authors:  Qing Xie; Weishu Bu; Smita Bhatia; Joan Hare; Thayumanasamy Somasundaram; Arezki Azzi; Michael S Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

Review 4.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

5.  Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.

Authors:  Joseph E Rabinowitz; Fabienne Rolling; Chengwen Li; Hervè Conrath; Weidong Xiao; Xiao Xiao; R Jude Samulski
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors.

Authors:  C L Halbert; J M Allen; A D Miller
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Brain dendritic cells and macrophages/microglia in central nervous system inflammation.

Authors:  H G Fischer; G Reichmann
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

8.  Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.

Authors:  Dirk Grimm; Mark A Kay; Juergen A Kleinschmidt
Journal:  Mol Ther       Date:  2003-06       Impact factor: 11.454

9.  Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors.

Authors:  M Cucchiarini; X L Ren; G Perides; E F Terwilliger
Journal:  Gene Ther       Date:  2003-04       Impact factor: 5.250

10.  HIV associated neurodegeneration requires p53 in neurons and microglia.

Authors:  Gwenn A Garden; Weiqun Guo; Suman Jayadev; Christina Tun; Stephanie Balcaitis; Jo Choi; Thomas J Montine; Thomas Möller; Richard S Morrison
Journal:  FASEB J       Date:  2004-05-20       Impact factor: 5.191

View more
  10 in total

1.  Directed evolution of adeno-associated virus for efficient gene delivery to microglia.

Authors:  Rui Lin; Youtong Zhou; Ting Yan; Ruiyu Wang; Heng Li; Zhaofa Wu; Xinshuang Zhang; Xiangyu Zhou; Fei Zhao; Li Zhang; Yulong Li; Minmin Luo
Journal:  Nat Methods       Date:  2022-07-25       Impact factor: 47.990

Review 2.  Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology.

Authors:  Fernando Pena-Ortega
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 3.  Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges.

Authors:  Margaret E Maes; Gloria Colombo; Rouven Schulz; Sandra Siegert
Journal:  Neurosci Lett       Date:  2019-05-31       Impact factor: 3.197

4.  High-Throughput Platform for Efficient Chemical Transfection, Virus Packaging, and Transduction.

Authors:  Jianxiong Zhang; Yawei Hu; Xiaoqing Wang; Peng Liu; Xiaofang Chen
Journal:  Micromachines (Basel)       Date:  2019-06-10       Impact factor: 2.891

Review 5.  AAV Targeting of Glial Cell Types in the Central and Peripheral Nervous System and Relevance to Human Gene Therapy.

Authors:  Simon J O'Carroll; William H Cook; Deborah Young
Journal:  Front Mol Neurosci       Date:  2021-01-11       Impact factor: 5.639

Review 6.  Distinct Cell-specific Roles of NOX2 and MyD88 in Epileptogenesis.

Authors:  Cayo Almeida; Renan Paschoalino Pongilio; Marília Inês Móvio; Guilherme Shigueto Vilar Higa; Rodrigo Ribeiro Resende; Jianxiong Jiang; Erika Reime Kinjo; Alexandre Hiroaki Kihara
Journal:  Front Cell Dev Biol       Date:  2022-07-04

7.  Chimeric GPCRs mimic distinct signaling pathways and modulate microglia responses.

Authors:  Rouven Schulz; Medina Korkut-Demirbaş; Alessandro Venturino; Gloria Colombo; Sandra Siegert
Journal:  Nat Commun       Date:  2022-08-15       Impact factor: 17.694

Review 8.  Herpes Simplex Virus: A Versatile Tool for Insights Into Evolution, Gene Delivery, and Tumor Immunotherapy.

Authors:  Prapti H Mody; Sushila Pathak; Laura K Hanson; Juliet V Spencer
Journal:  Virology (Auckl)       Date:  2020-05-29

9.  The pro-inflammatory microRNA miR-155 influences fibrillar β-Amyloid1 -42 catabolism by microglia.

Authors:  Macarena S Aloi; Katherine E Prater; Bryce Sopher; Stephanie Davidson; Suman Jayadev; Gwenn A Garden
Journal:  Glia       Date:  2021-03-10       Impact factor: 8.073

10.  Small nuclear RNA-mediated modulation of splicing reveals a therapeutic strategy for a TREM2 mutation and its post-transcriptional regulation.

Authors:  Motoaki Yanaizu; Kenji Sakai; Youhei Tosaki; Yoshihiro Kino; Jun-Ichi Satoh
Journal:  Sci Rep       Date:  2018-05-02       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.